ASCO CONFERENCE COVERAGE
ASCO CONFERENCE COVERAGE
05/22/2026
Anthony Calabro, MA
In a retrospective national VA cohort of nearly 1 million Veterans, tobacco smoking duration criteria identified more screening-eligible patients and fewer missed lung cancer diagnoses than pack-year...
05/22/2026
ASCO CONFERENCE COVERAGE
ASCO CONFERENCE COVERAGE
05/22/2026
Anthony Calabro, MA
In a phase 3 BWEL substudy, a lifestyle-based weight loss intervention improved patient-reported physical function, global health, social roles and activities, and fatigue in women with stage II-III breast...
05/22/2026
Research Summary
Research Summary
05/19/2026
Anthony Calabro, MA
A retrospective single-center study evaluates outcomes of patients refusing standard blood products in favor of directed “unvaccinated” donations.
05/19/2026
Long COVID Roundup
Long COVID Roundup
05/14/2026
Anthony Calabro, MA
Recent studies in children and adults associate long COVID with worsened academic performance, attention difficulties, subjective cognitive impairment, and persistent neurologic and psychiatric symptoms. ...
05/14/2026
Video
Video
05/14/2026
Brittany Albright, MD, MPH
In this video, Brittany Albright, MD, discusses why primary care clinicians are often the first line of defense in recognizing and treating anxiety disorders. She reviews practical strategies for screening,...
05/14/2026
FDA Approval
FDA Approval
05/13/2026
Anthony Calabro, MA
The FDA approved a once-daily, 2-drug oral regimen for adults with virologically suppressed HIV-1 to replace existing antiretroviral therapy.
05/13/2026
Video
Video
05/13/2026
Rakesh Jain, MD, MPH, RD
Many patients with major depressive disorder remain “stuck” in partial response despite treatment. In this Practical Updates in Primary Care recap, Rakesh Jain, MD, MPH, outlines strategies to identify...
05/13/2026
Research Summary
Research Summary
05/08/2026
Anthony Calabro, MA
An individual participant data meta-analysis clarifies which elements of collaborative care most effectively reduce depressive symptoms in primary care, informing implementation strategies for clinicians...
05/08/2026
FDA Approval
FDA Approval
05/04/2026
Anthony Calabro, MA
On May 1, the FDA approved vepdegestrant (Veppanu), a heterobifunctional protein degrader, for adults with estrogen receptor–positive, human epidermal growth factor receptor 2–negative, ESR1-mutated...
05/04/2026
Research Summary
Research Summary
05/04/2026
Kate Young
A randomized clinical trial evaluated whether a 6-month habit-focused lifestyle program could improve sustained remission of metabolic syndrome at 24 months compared with standard education and activity...
05/04/2026